Investoreight
Skip to main content

Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development

Yahoo! Finance
-- Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas -- -- Fast tracks establishment of Sanofi’s recently announced mRNA Center of Excellence -- -- Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology -- PARIS and LEXINGTON, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics
Continue Reading